All Stories

  1. A New Approach for Chagas Disease Screening Using Serum Infrared Spectroscopy and Machine Learning Algorithms
  2. Development and Validation of ELISA for In Vitro Diagnosis of SARS-CoV-2 Infection
  3. Multidisciplinary nursing care in chronic Chagas disease: a scoping review
  4. Comparison of Four Chimeric Antigens and Commercial Serological Assays for the Diagnosis of Trypanosoma cruzi Infection
  5. Chagas disease in Brazil: new challenges and perspectives for old problems
  6. Evaluation of nonpolar lipid extract antigen-based enzyme-linked immunosorbent assay for the serodiagnosis of tuberculosis
  7. Evaluation of QuantiFERON-TB Gold for the Diagnosis of Mycobacterium tuberculosis Infection in HTLV-1-Infected Patients
  8. Low-cost immunosensing approach for Chagas disease: exploiting modified pencil graphite electrodes with polymer films
  9. Assessing the performance of commercial serological tests for SARS-CoV-2 diagnosis
  10. Evaluation of chimeric recombinant antigens for the serodiagnosis of Trypanosoma cruzi in dogs: a promising tool for Chagas disease surveillance
  11. Comprehensive Study of the IBMP ELISA IgA/IgM/IgG COVID-19 Kit for SARS-CoV-2 Antibody Detection
  12. Performance Assessment of Treponemal and Nontreponemal Tests for the Diagnosis of Acquired Syphilis
  13. Feline leishmaniasis in an animal shelter in northeastern Brazil: Clinical aspects, coinfections, molecular detection, and serological study of a new recombinant protein
  14. IgG Isotypes Targeting a Recombinant Chimeric Protein of Trypanosoma cruzi in Different Clinical Presentations of Chronic Chagas Disease
  15. Post-therapeutic cure criterion in chronic Chagas disease using Trypanosoma cruzi chimeric proteins
  16. Usefulness of receptor binding domain protein-based serodiagnosis of COVID-19
  17. Evaluating the diagnostic accuracy of TpN17 and TmpA recombinant proteins in syphilis detection: a phase II study
  18. The Oxente Chagas Bahia Project: evaluating the efficacy of a rapid diagnostic test and treatments for Chagas disease
  19. Assessment of Cross-Reactivity of Chimeric Trypanosoma cruzi Antigens with Crithidia sp. LVH-60A: Implications for Accurate Diagnostics
  20. Seroepidemiological Survey of Chronic Chagas Disease in a Rural Community in Southern Bahia, Brazil, Using Recombinant Chimeric Antigens
  21. Seroepidemiology of Chagas disease in at-risk individuals in Caraíbas, a city with high endemicity in Bahia State, Brazil
  22. A multicenter comparative study of the performance of four rapid immunochromatographic tests for the detection of anti-Trypanosoma cruzi antibodies in Brazil
  23. Epidemiological indicators of Chagas disease in the metropolitan region of Salvador, Bahia, Brazil
  24. Guidelines for Trypanosoma cruzi-HIV Co-infection and other Immunosuppressive Conditions: Diagnosis, Treatment, Monitoring, and Implementation from the International Network of Care and Studies - 2023
  25. Western blot using Trypanosoma cruzi chimeric recombinant proteins for the serodiagnosis of chronic Chagas disease: A proof-of-concept study
  26. Spatiotemporal distribution analysis of syphilis in Brazil: Cases of congenital and syphilis in pregnant women from 2001–2017
  27. Technological advances in the serological diagnosis of Chagas disease in dogs and cats: a systematic review
  28. Integrative and Multidisciplinary Care for People Living With Human T-Cell Lymphotropic Virus in Bahia, Brazil: 20 Years of Experience
  29. Double-antigen sandwich ELISA based on chimeric antigens for detection of antibodies to Trypanosoma cruzi in human sera
  30. Performance of Chimeric Trypanosoma cruzi Antigens in Serological Screening for Chagas Disease in Blood Banks
  31. Distribution of Human Immunodeficiency Virus and Human T-Leukemia Virus Co-infection in Bahia, Brazil
  32. Eco-epidemiology of vectorial Trypanosoma cruzi transmission in a region of northeast Brazil
  33. Seroprevalence and detection of Trypanosoma cruzi in dogs living in a non-endemic area for Chagas disease in the legal Amazon region, Brazil
  34. Seroprevalence and Spatial Distribution of Hepatitis C Virus in Bahia, Brazil
  35. Stability Assessment of Four Chimeric Proteins for Human Chagas Disease Immunodiagnosis
  36. Parasitological cure in children infected with Trypanosoma cruzi
  37. Assessment of Liaison XL Murex Chagas diagnostic performance in blood screening for Chagas disease using a reference array of chimeric antigens
  38. Antibodies response induced by recombinant virus-like particles from Triatoma virus and chimeric antigens from Trypanosoma cruzi
  39. Novel Genetic Constructs for Production of Recombinant HTLV-1/2 Antigens and Evaluation of Their Reactivity to Plasma Samples from HTLV-1-Infected Patients
  40. Analysis of the Space and Time Distribution of Syphilis in Brazil: Cases of Acquired Syphilis from 2010-2018 and Congenital and Syphilis in Pregnant Women from 2001-2017
  41. Impedimetric immunosensor for rapid and simultaneous detection of chagas and visceral leishmaniasis for point of care diagnosis
  42. Analysis of the Space and Time Distribution of Syphilis in Brazil: Cases of Acquired Syphilis From 2010-2018 and Congenital and Syphilis in Pregnant Women From 2001-2017
  43. Correction: Performance of Treponema pallidum recombinant proteins in the serological diagnosis of syphilis
  44. Acute Chagas disease in Brazil from 2001 to 2018: A nationwide spatiotemporal analysis
  45. Distribution of Human T-Lymphotropic Virus (HTLV) and Hepatitis C Co-infection in Bahia, Brazil
  46. Performance of Treponema pallidum recombinant proteins in the serological diagnosis of syphilis
  47. Development of a New Lateral Flow Assay Based on IBMP‐8.1 and IBMP‐8.4 Chimeric Antigens to Diagnose Chagas Disease
  48. Infection by Strongyloides stercoralis in immigrants with Chagas disease: evaluation of eosinophilia as screening method in primary care
  49. Line Immunoassay for Confirmation and Discrimination of Human T-Cell Lymphotropic Virus Infections in Inconclusive Western Blot Serum Samples from Brazil
  50. Distribution of Human T-Lymphotropic Virus (HTLV) and Hepatitis C Co-infection in Bahia, Brazil
  51. A Cross-Sectional Study of Entamoeba histolytica/dispar/moshkovskii Complex in Salvador, Bahia, Brazil
  52. Performance of recombinant chimeric proteins in the serological diagnosis of Trypanosoma cruzi infection in dogs
  53. Cross-Reactivity Using Chimeric Trypanosoma cruzi Antigens: Diagnostic Performance in Settings Where Chagas Disease and American Cutaneous or Visceral Leishmaniasis Are Coendemic
  54. Evidence of New Endemic Clusters of Human T-Cell Leukemia Virus (HTLV) Infection in Bahia, Brazil
  55. Detection of anti-Trypanosoma cruzi antibodies by chimeric antigens in chronic Chagas disease-individuals from endemic South American countries
  56. Immune reactivity to Trypanosoma cruzi chimeric proteins for Chagas disease diagnosis in immigrants living in a non-endemic setting
  57. Seroprevalence of Trypanosoma cruzi infection among blood donors in the state of Bahia, Brazil
  58. Alterations in the lipid profiles and circulating liver enzymes in individuals infected by Schistosoma mansoni
  59. Highly Accurate Chimeric Proteins for the Serological Diagnosis of Chronic Chagas Disease: A Latent Class Analysis
  60. Performance of Commercially Available Serological Screening Tests for Human T-Cell Lymphotropic Virus Infection in Brazil
  61. Neglected tropical diseases in Brazilian children and adolescents: data analysis from 2009 to 2013
  62. Performance Assessment of a Trypanosoma cruzi Chimeric Antigen in Multiplex Liquid Microarray Assays
  63. Accuracy of chimeric proteins in the serological diagnosis of chronic chagas disease – a Phase II study
  64. Meloidogyne eggs in human stool in Northeastern Brazil
  65. Performance Assessment of Four Chimeric Trypanosoma cruzi Antigens Based on Antigen-Antibody Detection for Diagnosis of Chronic Chagas Disease
  66. Chronic Chagas Disease Diagnosis: A Comparative Performance of Commercial Enzyme Immunoassay Tests
  67. Spatiotemporal analysis of reported cases of acute Chagas disease in the State of Pernambuco, Brazil, from 2002 to 2013
  68. HOOKWORM AND THREADWORM INFECTIONS AND THEIR ASSOCIATION WITH HEMOGLOBIN AND EOSINOPHIL CONCENTRATIONS IN RESIDENTS OF SALVADOR-BAHIA, BRAZIL
  69. A Brazilian Case of Tongue Cysticercosis
  70. Efficacy of parasitological methods for the diagnosis of Strongyloides stercoralis and hookworm in faecal specimens
  71. Validation and utilization of PCR for differential diagnosis and prevalence determination of Entamoeba histolytica/Entamoeba dispar in Salvador City, Brazil
  72. Validation and utilization of PCR for differential diagnosis and prevalence determination of Entamoeba histolytica/Entamoeba dispar in Salvador City, Brazil
  73. Mecanismos fisiopatogênicos e diagnóstico laboratorial da infecção causada pela Entamoeba histolytica
  74. PREVALÊNCIA DE PARASITOSES INTESTINAIS EM PACIENTES ATENDIDOS NO HOSPITAL UNIVERSITÁRIO PROFESSOR EDGAR SANTOS, SALVADOR – BAHIA
  75. PREVALÊNCIA DE ENTEROPARASITOSESEM CRIANÇAS DO SERTÃO BAIANO
  76. The first confirmed case of Diphyllobothrium latum in Brazil
  77. Epidemiologia, fisiopatogenia e diagnóstico laboratorial da infecção pelo HTLV-I
  78. Comparison of the thick smear and Kato-Katz techniques for diagnosis of intestinal helminth infections
  79. Prevalência da infecção pelo vírus linfotrópico humano de células T e fatores de risco associados à soropositividade em doadores de sangue da cidade de Rio Branco, AC, Brasil (1998-2001)
  80. Globin Haplotypes of Human T-Cell Lymphotropic Virus Type I–Infected Individuals in Salvador, Bahia, Brazil, Suggest a Post-Columbian African Origin of This Virus